No abstract available
MeSH terms
-
Adjuvants, Immunologic / administration & dosage
-
Adjuvants, Immunologic / therapeutic use*
-
Administration, Cutaneous
-
Aged
-
Aged, 80 and over
-
Aminoquinolines / administration & dosage
-
Aminoquinolines / therapeutic use*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin / administration & dosage
-
Combined Modality Therapy
-
Dacarbazine / administration & dosage
-
Female
-
Humans
-
Imiquimod
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Knee
-
Leg
-
Lymphatic Metastasis
-
Male
-
Melanoma / drug therapy*
-
Melanoma / radiotherapy
-
Melanoma / secondary
-
Melanoma / surgery
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / radiotherapy
-
Neoplasm Recurrence, Local / surgery
-
Nitrosourea Compounds / administration & dosage
-
Organophosphorus Compounds / administration & dosage
-
Recombinant Proteins
-
Scalp
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Skin Neoplasms / radiotherapy
-
Skin Neoplasms / surgery
-
Treatment Outcome
Substances
-
Adjuvants, Immunologic
-
Aminoquinolines
-
Antineoplastic Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Nitrosourea Compounds
-
Organophosphorus Compounds
-
Recombinant Proteins
-
Dacarbazine
-
Carboplatin
-
fotemustine
-
Imiquimod